Literature DB >> 18424450

Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease.

Yun-Ping Wu1, Kiyomi Mizugishi, Meryem Bektas, Roger Sandhoff, Richard L Proia.   

Abstract

Sphingosine-1-phosphate (S1P) is a lipid-signaling molecule produced by sphingosine kinase in response to a wide number of stimuli. By acting through a family of widely expressed G protein-coupled receptors, S1P regulates diverse physiological processes. Here we examined the role of S1P signaling in neurodegeneration using a mouse model of Sandhoff disease, a prototypical neuronopathic lysosomal storage disorder. When sphingosine kinase 1 (Sphk1) was deleted in Sandhoff disease mice, a milder disease course occurred, with decreased proliferation of glial cells and less-pronounced astrogliosis. A similar result of milder disease course and reduced astroglial proliferation was obtained by deletion of the gene for the S1P(3) receptor, a G protein-coupled receptor enriched in astrocytes. Our studies demonstrate a functional role of S1P synthesis and receptor expression in astrocyte proliferation leading to astrogliosis during the terminal stages of neurodegeneration in Sandhoff disease mice. Because astrocyte responses are involved in many types of neurodegeneration, the Sphk1/S1P receptor signaling axis may be generally important during the pathogenesis of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424450      PMCID: PMC2548282          DOI: 10.1093/hmg/ddn126

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  45 in total

1.  Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.

Authors:  Francesco Paolo Di Giorgio; Monica A Carrasco; Michelle C Siao; Tom Maniatis; Kevin Eggan
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

2.  Role of ABCC1 in export of sphingosine-1-phosphate from mast cells.

Authors:  Poulami Mitra; Carole A Oskeritzian; Shawn G Payne; Michael A Beaven; Sheldon Milstien; Sarah Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-18       Impact factor: 11.205

3.  An essential role for the H218/AGR16/Edg-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability.

Authors:  A J MacLennan; P R Carney; W J Zhu; A H Chaves; J Garcia; J R Grimes; K J Anderson; S N Roper; N Lee
Journal:  Eur J Neurosci       Date:  2001-07       Impact factor: 3.386

4.  Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades.

Authors:  A Pébay; M Toutant; J Prémont; C F Calvo; L Venance; J Cordier; J Glowinski; M Tencé
Journal:  Eur J Neurosci       Date:  2001-06       Impact factor: 3.386

5.  Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.

Authors:  R Wada; C J Tifft; R L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 6.  Effects of LPA and S1P on the nervous system and implications for their involvement in disease.

Authors:  D R Herr; J Chun
Journal:  Curr Drug Targets       Date:  2007-01       Impact factor: 3.465

7.  Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons.

Authors:  Taketoshi Kajimoto; Taro Okada; Huan Yu; Sravan K Goparaju; Saleem Jahangeer; Shun-ichi Nakamura
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

8.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

Authors:  Y Liu; R Wada; T Yamashita; Y Mi; C X Deng; J P Hobson; H M Rosenfeldt; V E Nava; S S Chae; M J Lee; C H Liu; T Hla; S Spiegel; R L Proia
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

9.  Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis.

Authors:  Karolina Wosik; Romain Cayrol; Aurore Dodelet-Devillers; France Berthelet; Monique Bernard; Robert Moumdjian; Alain Bouthillier; Timothy L Reudelhuber; Alexandre Prat
Journal:  J Neurosci       Date:  2007-08-22       Impact factor: 6.167

10.  Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.

Authors:  Rajita Pappu; Susan R Schwab; Ivo Cornelissen; João P Pereira; Jean B Regard; Ying Xu; Eric Camerer; Yao-Wu Zheng; Yong Huang; Jason G Cyster; Shaun R Coughlin
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

View more
  41 in total

Review 1.  A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

Authors:  Jerold Chun; Volker Brinkmann
Journal:  Discov Med       Date:  2011-09       Impact factor: 2.970

Review 2.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

3.  Activation of Sphingosine-1-Phosphate Receptor 1 in the Spinal Cord Produces Mechanohypersensitivity Through the Activation of Inflammasome and IL-1β Pathway.

Authors:  Timothy M Doyle; Zhoumou Chen; Mariaconcetta Durante; Daniela Salvemini
Journal:  J Pain       Date:  2019-02-23       Impact factor: 5.820

Review 4.  Neuron-astroglial interactions in cell-fate commitment and maturation in the central nervous system.

Authors:  Joice Stipursky; Tânia Cristina Leite de Sampaio E Spohr; Vivian Oliveira Sousa; Flávia Carvalho Alcantara Gomes
Journal:  Neurochem Res       Date:  2012-05-22       Impact factor: 3.996

5.  Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome.

Authors:  Philippe M Campeau; Moutih Rafei; Marie-Noëlle Boivin; Ying Sun; Gregory A Grabowski; Jacques Galipeau
Journal:  Blood       Date:  2009-07-08       Impact factor: 22.113

Review 6.  Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Authors:  Richard L Proia; Timothy Hla
Journal:  J Clin Invest       Date:  2015-04-01       Impact factor: 14.808

Review 7.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

8.  Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways.

Authors:  Patrick Quint; Ming Ruan; Larry Pederson; Moustapha Kassem; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

Review 9.  The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy.

Authors:  Debra S Regier; Richard L Proia; Alessandra D'Azzo; Cynthia J Tifft
Journal:  Pediatr Endocrinol Rev       Date:  2016-06

10.  Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes.

Authors:  Luke M Healy; Graham K Sheridan; Adam J Pritchard; Aleksandra Rutkowska; Florian Mullershausen; Kumlesh K Dev
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.